Elsevier to Publish The Journal of Economic Asymmetries Beginning in January 2013
Oxford, December 19, 2012 –Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that they have entered into an agreement with the Athenian Policy Forum (APF) represented by Professor Anastasios G. Malliaris to publish The Journal of Economic Asymmetries (JEA), the official journal of APF beginning in January 2013.
The journal publishes scholarly articles on economic, financial, technological and legal asymmetries within and among markets in an increasingly globalized world. Editor Professor Anastasios G. Malliaris stated, "On behalf of the Board of Directors and the Fellows of the Athenian Policy Forum, I am delighted to see the Journal of Economic Asymmetries join Elsevier. We expect the wider visibility of the journal, now that it is part of the Elsevier family, will offer a much greater incentive to scholars and policy makers to submit their research papers to the journal. We wish to emphasize that the journal has three globally known co-editors who specialize in economic problems and associated policies across three geographical regions: the Americas, Europe and Asia."
Jenny Henzen, Economics Publisher at Elsevier said, "We are pleased to be announcing this new publishing agreement with APF and look forward to working with the Editor Professor Anastasios G. Malliaris.”
Effective January 1, 2013 Elsevier will publish The Journal of Economic Asymmetries.
For more information go to: www.elsevier.com/locate/jeca
# # #
About Athenian Policy Forum
The major objective of the Athenian Policy Forum is to promote independent objective analysis and stimulate public discussion on issues and problems relating to economic adjustment. It contributes to this goal by disseminating the results of innovative research on the economic implications of the changing forces of demography, the environment, social and political transformation, technology and trade.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+ 44 1865 843825